EcoDrugPlus

Ensembl ID : ENSCSAVG00000011821
Gene Symbol: -
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001747
Gene Symbol: -
1 Cross references
375 Possible Orthologues:

Ensembl ID : ENSCSAVG00000001105
Gene Symbol: -
1 Cross references
519 Possible Orthologues:

Ensembl ID : ENSCSAVG00000002010
Gene Symbol: -
1 Cross references
343 Possible Orthologues:

Ensembl ID : ENSCSAVG00000004318
Gene Symbol: -
1 Cross references
204 Possible Orthologues:

Ensembl ID : ENSCSAVG00000004353
Gene Symbol: -
1 Cross references
350 Possible Orthologues:

Ensembl ID : ENSCSAVG00000004583
Gene Symbol: -
1 Cross references
399 Possible Orthologues:

Ensembl ID : ENSCSAVG00000006343
Gene Symbol: -
1 Cross references
585 Possible Orthologues:

Ensembl ID : ENSCSAVG00000008472
Gene Symbol: -
1 Cross references
514 Possible Orthologues:

Ensembl ID : ENSCSAVG00000009125
Gene Symbol: -
1 Cross references
491 Possible Orthologues:

Ensembl ID : ENSCSAVG00000010834
Gene Symbol: -
1 Cross references
381 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).